European Association for the Study of Diabetes
LightNews LightNews
banner
easdnews.bsky.social
European Association for the Study of Diabetes
@easdnews.bsky.social
880 followers 96 following 380 posts
We promote excellence in #diabetes #care through #research, #networking and #education.

The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
Posts Replies Media Videos
easdnews.bsky.social
🧠Meet Dr. Jurga Laurencikiene (@ki.se) recipient of the #EFSD / @novonordisk.bsky.social A/S Programme for Diabetes Research in 🇪🇺 grant to explore the dual role of adipose tissue inflammation.

📚Publications:
1️⃣ pubmed.ncbi.nlm.nih.gov/39261467/
2️⃣ pubmed.ncbi.nlm.nih.gov/38460092/

#diabetesresearch
Recipient Research Portrait featuring Doctor Jurga Laurencikiene from Karolinska Institute, Huddinge. The design uses turquoise, lime green, and white curved elements. A circular photo shows a woman with wavy blonde hair wearing a dark blue patterned top, smiling at the camera in an office setting. The EFSD (European Foundation for the Study of Diabetes) logo appears at bottom left with their full name. Research project description slide with curved design elements in green, blue, and turquoise. Title reads 'Type 2 diabetes and adipose tissue morphology: dual role and sex-specificity of the immune component' in dark blue text on a mint green banner. Below, on a lime green background, text explains: 'Jurga Laurencikiene examines the crosstalk and interaction between inflammation and metabolism in human adipose tissue, providing insights into their regulation by sex hormones.' EFSD logo and name appear at bottom. Promotional graphic for the EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe. The design features curved blue and turquoise diagonal stripes on a light blue background. Text reads 'Supported by the' in a green banner at top, followed by the programme name in a teal box, and 'Apply for research grants and fellowships' in white text on a dark blue banner. Website europeandiabetesfoundation.org appears at bottom.
November 18, 2025 at 3:00 PM
easdnews.bsky.social
Hear different impressions from the EASD Academy's latest "Best of EASD 2025" videos, where #earlycareer #researchers share their highlights from the EASD 2025 Annual Meeting.

This week, Dr Eugenia Martín Vázquez discusses what's new in #T1D research.

Watch the full episode 👉 youtu.be/udpCzkq8l-s
November 17, 2025 at 12:34 PM
easdnews.bsky.social
✈️💙 Today on World Diabetes Day, we highlight how most countries still restrict people with diabetes from becoming pilots or air traffic controllers. The EASA Diabetes Project, led by Prof. Julia Mader (@medunigraz.at), is helping change that!

🔗👉 Read the full story: www.easd.org/worlddiabete...
A promotional graphic for World Diabetes Day 2025. At the top, large white text on a blue banner reads “World Diabetes Day 2025.” On the right is the World Diabetes Day logo (a blue circle) with the words “world diabetes day” and “14 November.” On the left side of the graphic is a group photo of around fifteen people standing together in front of two banners that read “EASA European Union.” Below the photo, a white and blue banner displays the text: “Prof. Julia Mader.” Next to it is a circular portrait of a woman with fair skin and dark hair, resting her chin on her hand. Large white text beneath reads: “Diabetes and the workplace: When ‘the’ sky is not the limit.” At the bottom left is the logo of the European Association for the Study of Diabetes (EASD), and at the bottom right is the website “easd.org.” The background uses overlapping geometric shapes in teal, blue, and light green.
November 14, 2025 at 9:38 AM
easdnews.bsky.social
Congrats to the 2025 #EFSD/@novonordisk.bsky.social A/S Programme for #DiabetesResearch in 🇪🇺 #grant recipients!🏆👏

Driving innovation across 🇪🇺 to advance knowledge & treatments for #diabetes.

Excited to see the impact of your research 👉 www.europeandiabetesfoundation.org/recipients/e...

#Funding
A graphic announcing the 2025 grant recipients of the EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe. The top of the image has a white text box with the program title in bold navy-blue letters. Below, “2025 Grant Recipients” is centred in white text on a green and teal geometric background. The recipients’ names, affiliations, and countries are listed in two rows: Top row: Hannele Yki-Järvinen, University of Helsinki, Finland, Maike Sander, Max Delbrück Center for Molecular Medicine, Germany, Amandine Gautier-Stein, University of Lyon, France Bottom row: Doris Kaltenecker, Helmholtz Munich, Germany, José Javier Fuster-Ortuño, National Center for Cardiovascular Research, Spain, Inga Prokopenko, University of Surrey, United Kingdom The EFSD logo appears in the bottom left corner, and the website “europeandiabetesfoundation.org” is shown at the bottom right on a light blue band. The design features overlapping blue and green shapes with circular accents in the top right
November 13, 2025 at 10:35 AM
easdnews.bsky.social
🎉 Happening Now! The EASD Scientists Training Course 2025 is in full swing this week @idibaps.bsky.social in beautiful Barcelona, Spain! 🇪🇸

📸 👇 Take a look at the image below and join us in wishing all participants continued success throughout the week!

Supported by Lilly Diabetes International
Group photo of participants at the EASD Scientists Training Course 2025, taken in an outdoor courtyard with greenery and historic buildings. The banner reads ‘EASD Scientists Training Course 2025’. Logos of European Association for the Study of Diabetes (EASD) and Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) are visible at the bottom.
November 12, 2025 at 2:00 PM
easdnews.bsky.social
A limitless supply of insulin-producing beta cells?

In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.

📺👉 Watch now: easd-elearning.eu/episode/346/...
November 12, 2025 at 1:03 PM
easdnews.bsky.social
📢 The 2nd EASD Diabetes Technology School is now open for applications:

📅 24 - 26 April 2026 |📍Vienna, Austria

A 3 day course for #healthcare professionals to enhance their expertise in #diabetes #technology.

Apply by 5 January 2026 👉 www.easd.org/education/me...

#MedicalTraining #innovation
Promotional graphic for the 2nd Diabetes Technology School. The banner features a blue gradient background with white and navy text reading: ‘2nd Diabetes Technology School, 16 - 18 April 2026, Vienna, Austria.’ On the right side, diagonal image panels show close-up shots of diabetes technology devices, including a glucose monitor, an insulin pump, and wearable sensors on the skin. Text along the panels reads: ‘Advances in Diabetes Technology’ and ‘Innovations and Applications.’ The EASD logo and website easd.org appear at the bottom.
November 12, 2025 at 10:42 AM
easdnews.bsky.social
🧠 Meet Prof. Fredrik Bäckhed (BackhedLab), recipient of the 2023 #EFSD/ Novo Nordisk A/S Programme for #Diabetes #Research in Europe grant. His team showed that colonic GLP-1 is essential for #gut function & survival in the absence of #bacteria.

📖 Read more: www.sciencedirect.com/science/arti...
Recipient Research Portrait featuring Professor Fredrik Bäckhed from University of Gothenburg. The design includes a circular photo of a Professor Fredrik Bäckhed with short gray hair wearing a dark green sweater over a light blue collared shirt, set against a modern geometric background with turquoise, light blue, and lime green curved shapes. The EFSD (European Foundation for the Study of Diabetes) logo appears at the bottom. Title slide with the heading 'Gut microbial regulation of colonic GLP-1 production and effects on gut physiology' on a teal banner at the top. Below, on a lime green section, text explains: 'Fredrik Bäckhed's research aims to understand the role of colonic GLP-1 in gut physiology using mice with a targeted deficiency of GLP-1 production specifically in the colon.' The background features abstract curved shapes in light blue and dark blue. The EFSD logo is positioned at the bottom. Informational slide with 'Supported by the' in a lime green box at top left, followed by 'EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe' in a teal section. The bottom portion features a dark blue banner with large white text reading 'Apply for research grants and fellowships' and the website 'europeandiabetesfoundation.org'. The background includes abstract curved shapes in light blue, turquoise, and dark blue. The EFSD logo appears at bottom left
November 11, 2025 at 2:06 PM
easdnews.bsky.social
We’re thrilled to confirm the 2nd Early Career Academy Meeting:

📅 30 March - 1 April 2026 |📍 Düsseldorf, Germany

This meeting will bring together early career researchers to connect & collaborate on advancing #diabetes #research & #care.

📝 Apply by 2 December 2025

🔗👉 www.easd.org/academy/acad...
November 10, 2025 at 1:09 PM
easdnews.bsky.social
💻🗣️ #Webinar Alert! On #WorldDiabetesDay, join the EASD Early Career Academy with Prof. Gernot Desoye (@medunigraz.at ) as he discusses how the placenta influences pregnancy outcomes & protects the fetal brain.

📅 14 Nov 2025 |🕓16:00 CET

🔗 Register: us06web.zoom.us/webinar/regi...

#DiabetesResearch
November 7, 2025 at 2:24 PM
easdnews.bsky.social
🎙️ Weekend listening recommendation!

At #EASD2025, Prof. Raphael Scharfmann (@inserm.fr) was awarded the 19th Albert Renold Prize for his work on beta cells & type 1 diabetes. From stem cell advances to measuring beta cell mass in humans - a must-listen!

🎧Listen now 👉 www.easd.org/media-centre...
Dr Raphael Scharfmann speaking into a microphone during an interview at EASD2025 in Vienna. The image is framed with blue circular graphics and the EASD logo. Text on the image reads: “Pancreas development - key to unexpected diabetes treatments."
November 7, 2025 at 10:04 AM
easdnews.bsky.social
❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
November 5, 2025 at 2:50 PM
easdnews.bsky.social
🧠 Meet Dr Ilke Sen (@ki.se), #EFSD/ Lilly Young Investigator Awardee. Her study revealed a new RNA molecule, TMEM9B-AS1, that helps maintain muscle protein synthesis. Its loss in #type2diabetes may explain muscle weakness & mass loss.

📖 Read the full study: www.science.org/doi/10.1126/...

#lncRNA
Graphic titled ‘Recipient Research Portrait’ featuring Assistant Professor Ilke Sen from the Mondor Biomedical Research Institute, Créteil, and Karolinska Institute, Stockholm. Includes a circular portrait of her and EFSD - European Foundation for the Study of Diabetes - branding Graphic titled ‘Role of long non-coding RNAs in the regulation of skeletal muscle metabolism.’ Text describes Ilke Sen’s research on how long non-coding RNAs (lncRNAs) regulate skeletal muscle metabolism, insulin sensitivity, and function in type 2 diabetes and exercise response, aiming to identify molecular targets for improving muscle health and treating metabolic disorders. EFSD logo included Graphic with EFSD branding stating that the research is supported by the EFSD/Lilly Young Investigator Research Award Programme. The lower section invites viewers to apply for research grants and fellowships at europeandiabetesfoundation.org.
November 4, 2025 at 1:48 PM
easdnews.bsky.social
🚨 Early career #researchers don’t miss your chance to apply for the EASD Robert Turner Clinical Research Training Course!🌍Enhance your research skills & connect with peers:

📅 16 - 20 March 2026, Oxford, UK
🔗 Application deadline: 5 Jan 2026

Apply now 👉 www.easd.org/education/me...

#Diabetes
Banner for the EASD Robert Turner Clinical Research Training Course, taking place 16–20 March 2026 in Oxford, UK. Includes a red corner label reading ‘Apply Now!’ and images of Oxford landmarks, including the Radcliffe Camera and surrounding university buildings. The logo of the European Association for the Study of Diabetes (EASD) and website easd.org are displayed at the bottom.
November 3, 2025 at 10:44 AM
easdnews.bsky.social
🎙️ New #podcast episode out now!

Listen to the #easd2025 Rising Stars in #diabetes #research - Four young scientists shaping the future of diabetes share what drives their research & their hopes for the next decade in diabetes science.

🎧👉 Listen now: www.easd.org/mediacentre/...
A group of four people sit in chairs having a panel discussion, holding blue microphones, in front of a wooden wall. The design overlay includes the EASD logo and a soundwave graphic. Text reads: “Rising Stars: the future of diabetes research.
October 31, 2025 at 12:35 PM
easdnews.bsky.social
🎉👏Congrats to the 2025 #EFSD/ Novo Nordisk Foundation #FutureLeaders Award #recipients! Supporting scientists & clinicians in EU #diabetes #research as they transition into independent faculty roles.

Stay tuned for updates on their projects!

🔗👉 www.europeandiabetesfoundation.org/recipients/e...
Graphic announcing the EFSD/Novo Nordisk Foundation Future Leaders Award 2025 recipients. The banner features blue, green, and turquoise colours with circular design elements. The text reads: ‘EFSD/Novo Nordisk Foundation Future Leaders Award - 2025 Award Recipients.’ Listed recipients: Joan Camunas-Soler, University of Gothenburg, Sweden; Martin Schön, German Diabetes Center, Germany; Rasmus Kjøbsted, University of Copenhagen, Denmark; and Amna Khamis, University of Lille, France. At the bottom are the EFSD logo and website: europeandiabetesfoundation.org.
October 30, 2025 at 10:39 AM
easdnews.bsky.social
👉 1 in 5 with #prediabetes achieved normal glucose regulation w/out weight loss – reducing their relative risk of #T2D by 71%.
Prevention guidelines centred on weight-loss targets risk overlooking an effective, patient-relevant goal, warns co-PI Andreas Birkenfeld: easd-elearning.eu/news/458/Rev...
Two scientific charts showing long-term diabetes outcomes. Left chart titled ‘Proportion of individuals without type 2 diabetes over time’ displays a survival curve comparing responders (in blue) and nonresponders (in red) over 10 years. The y-axis shows the percentage of individuals with no progression to type 2 diabetes, and the x-axis shows time in years. Responders maintain a higher proportion without diabetes compared to nonresponders. Statistical note: p = 0.004. Right chart titled ‘Glycaemic categories over time’ presents stacked bar graphs showing the number of participants with type 2 diabetes (green), prediabetes (yellow), and normal glucose regulation (light green) at different follow-up points (intervention outcome, 1, 2, 5, and 8 years). It includes a label indicating ‘Relative risk of type 2 diabetes: 0.29 (95% CI: 0.09–0.91, p = 0.02).
October 29, 2025 at 1:18 PM
easdnews.bsky.social
🧠 Meet Dr. Liva Krogh (Center for Clinical Metabolic Research), co-Investigator & #grant recipient of the #EFSD/ @novonordisk.bsky.social A/S Programme for Diabetes Research in 🇪🇺 for how GIP & GLP-1 affect tissues beyond the pancreas.

Learn more 👉 www.europeandiabetesfoundation.org/programmes.h...
Graphic titled ‘Recipient Research Portrait’ featuring Doctor Liva Sophie Lavlund Krogh from the Center for Clinical Metabolic Research, Gentofte Hospital. The design includes a portrait photo of her smiling, along with EFSD, European Foundation for the Study of Diabetes, branding. Graphic titled ‘Separate and combined extrapancreatic effects of the incretin hormones.’ Text explains that Liva Sophie Lavlund Krogh investigates the extrapancreatic effects of the incretin hormones GIP and GLP-1 in totally pancreatectomized patients, showing their impact on various tissues independent of pancreatic insulin and glucagon. EFSD logo included. Graphic with EFSD branding stating that the research is supported by the EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe. The lower section invites viewers to apply for research grants and fellowships at europeandiabetesfoundation.org
October 28, 2025 at 2:31 PM
easdnews.bsky.social
🔁The EASD Early Career Academy continues its #Webinar series! Next on #WorldDiabetesDay: Prof. Gernot Desoye ( @medunigraz.at ) explores how the #placenta influences #pregnancy outcomes and fetal development.

📅 14 November 2025 |🕛 16:00 pm CET

Register now 👉 us06web.zoom.us/webinar/regi...
October 27, 2025 at 1:45 PM
easdnews.bsky.social
📢 Job Opportunity: @easdnews.bsky.social is seeking an Editor-in-Chief for its flagship journal, @diabetologiajnl.bsky.social .

Lead one of the world’s top #diabetes #research journals.

🔗 Apply now: tinyurl.com/diab-eic-job...

🗓️ Closing date: 17 Nov 2025

#Diabetologia #Vacancy #EditorInChief
Announcement from the European Association for the Study of Diabetes (EASD) advertising the position of Editor-in-Chief, Diabetologia. The text invites accomplished physicians and scientists to apply to lead the journal, which publishes clinical, translational, and experimental research on diabetes. Includes application details via https://tinyurl.com/diab-eic-job-ad, contact email diabetologia-j@bristol.ac.uk, and notes the closing date for applications as 17 November 2025.
October 27, 2025 at 11:49 AM
easdnews.bsky.social
🌏 With >100 million people living with diabetes, how can we create lasting impact?

Dr. V. Mohan, recipient of the inaugural EASD #GlobalImpactPrize, shares 50 years of work shaping diabetes prevention, #education & #care in India.

🎧👉 Listen now: easd.org/media-centre/podcasts.html

#podcast
A smiling Dr. Viswanathan Mohan in a suit and patterned tie speaks into a blue microphone labeled “EASD Live.” The background has blue circular design elements and the EASD logo. Text on the image reads, “Impacting lives with diabetes in resource constrained settings.
October 24, 2025 at 11:09 AM
easdnews.bsky.social
Don't miss our first Immunology School for Endocrinology! Led by Prof. Chantal Mathieu & Prof. Julia Mader, this 2-day course covers immunology in #T1D, from new concepts to beta-cell replacement.

📅 26 - 27 March 2026 |📍 Vienna

🕛 Application Deadline: 30 Nov 2025

🔗👉 www.easd.org/education/me...
Banner for the 1st Immunology School for Endocrinology, taking place 26–27 March 2026 in Vienna, Austria. Organized by the European Association for the Study of Diabetes (EASD). The right side of the banner shows images of virus-like structures and a healthcare professional performing a finger-prick blood test.
October 23, 2025 at 9:02 AM
easdnews.bsky.social
📜 Certificates Now Available!

#easd2025 registered participants can now download their EACCME certificates as well as their Certificates of Attendance for the Annual Meeting directly from their #MyEASD account.

🔗👉 For more, visit: www.easd.org/annual-meeti...

#Diabetes #Certification #CME
Graphic announcing CME certificates for the 61st EASD Annual Meeting. The banner features a red background with blue and white text reading: ‘61st EASD Annual Meeting, 15 - 19 September 2025, Vienna, Austria.’ Below, a white and blue section says: ‘Now available - CME Certificates. EASD 2025 participants can now download their EACCME Certificate.’ The EASD 2025 Vienna logo appears in the top left corner, and the EASD logo with website easd.org is at the bottom.
October 22, 2025 at 1:15 PM
easdnews.bsky.social
Can #CGM use of just 10 to 15 days at a time make a difference in #T2D?

Dr. @dramitaol.bsky.social explains how intermittent CGM helps personalise care, optimise treatment & support #lifestyle modifications.

🎥👉 Watch now: easd-elearning.eu/episode/345/...

#Diabetes #technology #GlycaemicControl
October 22, 2025 at 12:07 PM
easdnews.bsky.social
Meet Prof. Kristina Schoonjans ( #EPFL), recipient of the #EFSD/#Boehringer Ingelheim European Research Programme grant. Her team explores how Clostridium scindens may prevent obesity & #t2d by restoring metabolic balance through bile acid signalling.

📖 Learn more👉 www.embopress.org/doi/epdf/10....
Call to action encouraging applications for research grants and fellowships at europeandiabetesfoundation.org. The image notes support from the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.' Research summary titled 'Targeting obesity and diabetes through microbiome-tailored bile acid signalling.' It explains Professor Kristina Schoonjans' investigation into using the gut bacterium Clostridium scindens to restore metabolic balance in obese mice and potentially develop a probiotic strategy against metabolic diseases like obesity and type 2 diabetes. Call to action encouraging applications for research grants and fellowships at europeandiabetesfoundation.org. The image notes support from the EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes.'
October 21, 2025 at 11:38 AM